Log In
Print this Print this

Libod, doxorubicin hydrochloride

  Manage Alerts
Collapse Summary General Information
Company Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
DescriptionDoxorubicin hydrochloride liposome formulation suing Stealth technique
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today